Skip to main content

Table 4 Comparison of clinical outcome

From: Effect of remimazolam besylate on elderly patients with mechanical ventilation: a single-center randomized controlled study

 

Control group median (IQR)

Experimental group median (IQR)

χ2

P

Hospital mortality (rates)

  

0.738

0.39

yes

9 (22.50)

6 (15.00)

  

no

31 (77.50)

34 (85.00)

  

Live in 28 days (rates)

  

0.001

0.98

yes

16 (69.57)

18 (69.23)

  

no

7 (30.43)

8 (30.77)

  

Invasive mechanical ventilation time (h)

107.50 (63.75, 142.75)

104.50(70.00,138.00)

0.038

0.069

ICU length of stay

7.00 (5.00,8.00)

7.00 (5.00, 8.50)

0.52

0.603